Alkemi Growth Capital plans $125-150 million third fund launch in 2027

Alkemi Growth Capital, a healthcare-focused venture capital firm, has announced plans to launch its third fund in the first half of 2027. The fund is expected to raise between $125 million and $150 million, with a strategic focus on deep-tech startups, preventive medicine, and healthcare innovation.
This development is significant for investors as it signals continued confidence in the healthcare sector, particularly in early-stage deep-tech ventures. The fund's specific focus areas could provide exposure to high-growth opportunities in the preventive medicine space, which is gaining increasing attention globally.
Investors should watch for updates on the fund's final size and its specific portfolio allocation. The success of this fund will likely depend on the firm's ability to identify and back promising deep-tech startups in a competitive market.
Key takeaways
- Category: Corporate Action.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.










